Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population.

Trial Profile

Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Feb 2013

At a glance

  • Drugs Scorpion venom antitoxin (Primary)
  • Indications Scorpion venom poisoning
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 18 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top